8,700 Studies Reviewed. 87.0% Found Biological Effects. The Evidence is Clear.
Shield Your Body
Cancer & Tumors

Hambarde S, Pandey A, Baskin DS, Helekar SA

Bioeffects Seen

Authors not listed · 2026

Share:

Spinning oscillating magnetic fields can selectively kill brain cancer cells while sparing healthy cells.

Plain English Summary

Summary written for general audiences

Researchers developed a new magnetic device that uses spinning oscillating magnetic fields to selectively kill aggressive brain cancer cells while leaving healthy brain cells unharmed. The device works by damaging the energy-producing parts of cancer cells, causing them to die through a natural cell death process. This represents a potentially safer approach to treating deadly brain cancers like glioblastoma.

Why This Matters

This study represents a fascinating example of how electromagnetic fields can be harnessed therapeutically rather than simply viewed as potential health hazards. The spinning oscillating magnetic field technology demonstrates remarkable selectivity, targeting cancer cells while sparing normal astrocytes. What makes this particularly significant is the mechanism of action: the fields specifically disrupt mitochondrial complex I in cancer cells, leading to oxidative stress and programmed cell death. This selectivity suggests that certain electromagnetic field parameters can exploit fundamental differences between healthy and malignant cells. The research provides important context for the broader EMF health debate by showing that field characteristics like frequency, intensity, and modulation patterns matter enormously. Not all electromagnetic exposures are created equal, and this therapeutic application underscores the importance of understanding specific biological mechanisms rather than making blanket assumptions about EMF effects.

Exposure Information

Specific exposure levels were not quantified in this study.

Cite This Study
Unknown (2026). Hambarde S, Pandey A, Baskin DS, Helekar SA.
Show BibTeX
@article{hambarde_s_pandey_a_baskin_ds_helekar_sa_ce4747,
  author = {Unknown},
  title = {Hambarde S, Pandey A, Baskin DS, Helekar SA},
  year = {2026},
  doi = {10.1002/1873-3468.70271},
  
}
DOI: 10.1002/1873-3468.70271PubMed: 41510612

Quick Questions About This Study

Research shows spinning oscillating magnetic fields from the Oncomagnetic device can selectively kill glioblastoma cells while leaving normal brain cells unharmed. The fields disrupt cancer cell energy production, leading to cell death through natural processes.
The spinning oscillating magnetic fields specifically inhibit mitochondrial complex I in cancer cells, disrupting their energy production. This creates reactive oxygen species and oxidative stress that ultimately triggers programmed cell death in the malignant cells.
Normal human astrocytes and brain cells showed no toxic effects from the same spinning oscillating magnetic fields that killed cancer cells. This selectivity appears related to fundamental metabolic differences between healthy and malignant cells.
The spinning oscillating magnetic fields cause DNA damage in glioma cells as part of the cell death process. This damage occurs after mitochondrial disruption and contributes to G1 phase cell cycle arrest and eventual apoptosis.
Yes, the spinning oscillating magnetic fields showed selective cytotoxicity against both glioblastoma and diffuse intrinsic pontine glioma cells. Both types of aggressive brain cancers responded to the treatment while normal cells remained unaffected.